查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1392002

细菌性涎腺炎市场：按类型、按细菌类型、按腺体类型、按药物类别、按配销通路、按地区

Bacterial Sialadenitis Market, By Type, By Type of Bacteria, By Gland Type, By Drug Class, By Distribution Channel, By Geography
出版日期: | 出版商: Coherent Market Insights | 英文 130 Pages | 商品交期: 2-3个工作天内

价格
简介目录

细菌性唾液腺炎的全球市场规模预计将从 2023 年的 4.678 亿美元增加到 2030 年的 6.644 亿美元，预测期内复合年增长率为 5.1%。

报告范围 报告详情
基准年 2022年 2023年市场规模 4.678 亿美元
实绩资料 2018-2021 预测期 2023-2030
预测期复合年增长率 5.10% 2030年市场规模预测 6.644 亿美元
图 1. 2023 年细菌性涎腺炎的全球市场占有率（%），依地区划分
细菌性涎腺炎市场-IMG1

唾液腺炎是主要唾液腺肿胀或肿大：腮腺（双耳前面）、下颔腺（口腔底部、舌下）和舌下腺（口腔后部、舌下） 。它可以是急性的（突然的）、慢性的（长期的）或復发性的。这种情况是由唾液腺导管感染或阻塞引起的。金黄色葡萄球菌是细菌性唾液腺炎的常见原因，但其他微生物也可能引起此疾病。细菌性唾液腺炎通常会带来疼痛，并可能包括发烧和发冷。受影响的唾液腺肿胀、发红、触痛，并且通常在中心变色，这可能表示脓肿。

预防措施包括良好的口腔卫生、多喝水以及解决增加细菌性唾液腺炎风险的潜在疾病。您可以透过定期进行牙科护理并避免危险因素来降低患这种疾病的机会。细菌性唾液腺炎的主要治疗方法是针对引起感染的特定细菌的抗生素治疗。也建议充足的水分、热敷和唾液腺按摩，以促进唾液流动并缓解症状。在某些情况下，可能需要手术干预来去除唾液腺结石或排放脓肿。

市场动态：

由于唾液腺感染疾病、唾液腺炎和修格兰氏症候群自体自体免疫疾病的盛行率不断上升，预计全球细菌性唾液腺炎市场在未来几年将显着增长。

预计高昂的治疗成本和与感染相关的併发症将阻碍全球细菌性唾液腺炎市场的成长。

本研究的主要特点

  • 该报告对全球细菌性唾液腺炎市场进行了详细分析，并提供了以2022年为基准年的预测期（2023-2030）的市场规模和年复合成长率（CAGR%）。
  • 它还揭示了各个细分市场的潜在商机，并为该市场说明了一系列有吸引力的投资提案。
  • 它还提供了有关市场驱动因素、抑制因素、机会、新产品发布和核准、市场趋势、区域前景、主要企业采取的竞争策略等的重要考察。
  • 它根据公司亮点、产品系列、主要亮点、绩效和策略等参数，介绍了全球细菌性唾液腺炎市场的主要企业。
  • 该报告的见解使行销人员和公司负责人能够就未来的产品发布、升级、市场扩张和行销策略做出明智的资讯。
  • 全球细菌性涎腺炎市场报告针对该行业的各个相关人员，如投资者、供应商、产品製造商、经销商、新进业者和财务分析师。
  • 相关人员可以透过用于分析全球细菌性唾液腺炎市场的各种策略矩阵来促进他们的决策。

目录

第一章 研究目的与前提

  • 研究目标
  • 假设
  • 简称

第二章 市场展望

  • 报告说明
    • 市场定义和范围
  • 执行摘要
  • Coherent Opportunity Map（COM）

第三章市场动态、法规及趋势分析

  • 市场动态
  • 影响分析
  • 主要亮点
  • 监管场景
  • 产品发布/核准
  • PEST分析
  • 波特的分析
  • 併购场景

第四章细菌性唾液腺炎市场 -冠状病毒（COVID-19）大流行的影响

  • 新型冠状病毒感染疾病（COVID-19）的流行病学
  • 供需面分析
  • 经济影响

第五章细菌性唾液腺炎市场，依类型，2018-2030

  • 急性
  • 慢性的

第六章细菌性唾液腺炎市场，依细菌型，2018-2030

  • 金黄色葡萄球菌
  • 草绿色链球菌
  • 铜绿假单胞菌
  • 大肠桿菌
  • 其他的

第 7 章 细菌性唾液腺炎市场，依腺体类型，2018-2030

  • 副状
  • 颚下
  • 舌下

第 8 章细菌性唾液腺炎市场，依药物类别，2018-2030

  • 抗生素
  • 双氯西林
  • 头孢菌素
  • 克林霉素

第 9 章细菌性唾液腺炎市场，按配销通路，2018-2030

  • 医院药房
  • 零售药房
  • 电子商务

第10章细菌性唾液腺炎市场，按地区，2018-2030

  • 北美洲
  • 美国
  • 加拿大
  • 欧洲
  • 英国
  • 德国
  • 义大利
  • 法国
  • 西班牙
  • 俄罗斯
  • 其他欧洲国家
  • 亚太地区
  • 中国
  • 印度
  • 日本
  • ASEAN
  • 澳洲
  • 韩国
  • 其他亚太地区
  • 拉丁美洲
  • 巴西
  • 墨西哥
  • 阿根廷
  • 其他拉丁美洲
  • 中东
  • GCC
  • 以色列
  • 其他中东地区
  • 非洲
  • 北非
  • 南非
  • 中部非洲

第十一章竞争形势

  • Pfizer Inc.
  • Merck & Co., Inc.
  • GlaxoSmithKline plc
  • Novartis AG
  • Sanofi SA
  • Johnson & Johnson
  • Abbott Laboratories
  • Eli Lilly and Company
  • AstraZeneca plc.
  • Bayer AG

第12章 章节

  • 调查方法
  • 关于出版商
简介目录
Product Code: CMI5810

The global bacterial sialadenitis market size is projected to reach US$ 664.4 million by 2030, from US$ 467.8 million in 2023, growing at a CAGR of 5.1% during the forecast period.

Report Coverage Report Details
Base Year: 2022 Market Size in 2023: US$ 467.8 Mn
Historical Data for: 2018 to 2021 Forecast Period: 2023 - 2030
Forecast Period 2023 to 2030 CAGR: 5.10% 2030 Value Projection: US$ 664.4 Mn
Figure 1. Global Bacterial sialadenitis Market Share (%), by Region, 2023
Bacterial Sialadenitis Market - IMG1

Sialadenitis is swelling and enlargement of the major salivary glands, the parotid (in front of each ear), submandibular (under the tongue on the floor of the mouth) or sublingual (below the tongue in the back of the mouth). It can be acute (sudden) or chronic (long-term) or recurrent. The condition can be caused by infection or by a blockage of the gland's ducts. A common cause of bacterial sialadenitis is Staphylococcus aureus, but other organisms may also be responsible. Bacterial sialadenitis is usually painful and may be accompanied by fever and chills. The affected gland is swollen, red and tender and usually has a central area of discoloration, which may indicate an abscess.

Preventive measures include maintaining good oral hygiene, drinking enough water, and addressing underlying conditions that increase the risk of bacterial sialadenitis. Regular dental care and avoiding risk factors can help reduce the likelihood of developing the condition. The primary treatment for bacterial sialadenitis is antibiotic therapy to target the specific bacteria causing the infection. Adequate hydration, warm compresses, and gland massage may also be recommended to promote saliva flow and relieve symptoms. In some cases, surgical intervention may be necessary to remove salivary stones or drain abscesses.

Market Dynamics:

The global bacterial sialadenitis market is expected to witness significant growth in the coming years owing to rising incidence of conditions such as salivary gland infections, sialadenitis, and autoimmune diseases such as Sjogren's syndrome.

High cost of treatment and complications associated with the infection are expected to hinder growth of the global bacterial sialadenitis market over the forecast.

Key features of the study:

  • This report provides an in-depth analysis of the global bacterial sialadenitis market, and provides market size (US$ Million) and compound annual growth rate (CAGR%) for the forecast period (2023-2030), considering 2022 as the base year
  • It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
  • It profiles key players in the global bacterial sialadenitis market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
  • Key companies covered as a part of this study include Pfizer Inc., Merck & Co., Inc., GlaxoSmithKline plc, Novartis AG, Sanofi S.A., Johnson & Johnson, Abbott Laboratories, Eli Lilly and Company, AstraZeneca plc, Bayer AG, Bristol-Myers Squibb Company, Roche Holding AG, Teva Pharmaceutical Industries Ltd., Mylan N.V., and Allergan plc.
  • Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
  • The global bacterial sialadenitis market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
  • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global bacterial sialadenitis market

Detailed Segmentation:

  • By Type:
    • Acute
    • Chronic
  • Type of Bacteria:
    • Staphylococcus aureus
    • Streptococcus viridans
    • Pseudomonas aeruginosa
    • Escherichia coli
    • Others (Haemophilus influenza, etc.)
  • By Gland Type:
    • Parotid
    • Submandibular
    • Sublingual
  • By Drug Class
    • Antibiotics
    • Dicloxacillin
    • Cephalosporin
    • Clindamycin
    • Analgesics
  • By Distribution Channel:
    • Hospitals Pharmacies
    • Retail Pharmacies
    • Ecommerce
  • By Region:
    • North America
    • Europe
    • Asia Pacific
    • Middle East and Africa
    • Latin America
  • Company Profiles:
    • Pfizer Inc.
    • Merck & Co., Inc.
    • GlaxoSmithKline plc
    • Novartis AG
    • Sanofi S.A.
    • Johnson & Johnson
    • Abbott Laboratories
    • Eli Lilly and Company
    • AstraZeneca plc
    • Bayer AG
    • Bristol-Myers Squibb Company
    • Roche Holding AG
    • Teva Pharmaceutical Industries Ltd.
    • Mylan N.V.
    • Allergan plc.

Table of Contents

1. Research Objectives and Assumptions

  • Research Objectives
  • Assumptions
  • Abbreviations

2. Market Purview

  • Report Description
    • Market Definition and Scope
  • Executive Summary
    • Market Bacterial Sialadenitis Market, By Type
    • Market Bacterial Sialadenitis Market, By Type of Bacteria
    • Market Bacterial Sialadenitis Market, By Gland Type
    • Market Bacterial Sialadenitis Market, By Drug Class
    • Market Bacterial Sialadenitis Market, By Distribution Channel
    • Market Bacterial Sialadenitis Market, By Region
  • Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

  • Market Dynamics
    • Drivers
    • Restraints
    • Opportunities
  • Impact Analysis
  • Key Highlights
  • Regulatory Scenario
  • Product launch/Approvals
  • PEST Analysis
  • PORTER's Analysis
  • Merger and Acquisition Scenario

4. Bacterial Sialadenitis Market - Impact of Coronavirus (COVID-19) Pandemic

  • COVID-19 Epidemiology
  • Supply Side and Demand Side Analysis
  • Economic Impact

5. Bacterial Sialadenitis Market, By Type, 2018-2030, (US$ Mn)

  • Introduction
    • Market Share Analysis, 2023 and 2030 (%)
    • Y-o-Y Growth Analysis, 2019 - 2030
    • Segment Trends
  • Acute
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Mn)
  • Chronic
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Mn)

6. Bacterial Sialadenitis Market, By Type of Bacteria, 2018-2030, (US$ Mn)

  • Introduction
    • Market Share Analysis, 2023 and 2030 (%)
    • Y-o-Y Growth Analysis, 2019 - 2030
    • Segment Trends
  • Staphylococcus aureus
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Mn)
  • Streptococcus viridans
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Mn)
  • Pseudomonas aeruginosa
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Mn)
  • Escherichia coli
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Mn)
  • Others
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Mn)

7. Bacterial Sialadenitis Market, By Gland Type, 2018-2030, (US$ Mn)

  • Introduction
    • Market Share Analysis, 2023 and 2030 (%)
    • Y-o-Y Growth Analysis, 2019- 2030
    • Segment Trends
  • Paratoid
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Million)
  • Submandibular
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Million)
  • Sublingual
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Million)

8. Bacterial Sialadenitis Market, By Drug Class, 2018-2030, (US$ Mn)

  • Introduction
    • Market Share Analysis, 2023 and 2030 (%)
    • Y-o-Y Growth Analysis, 2019- 2030
    • Segment Trends
  • Antibiotics
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Million)
  • Dicloxacillin
  • Cephalosporin
  • Clindamycin
    • Analgesic
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Million)

9. Bacterial Sialadenitis Market, By Distribution Channel, 2018-2030, (US$ Mn)

  • Introduction
    • Market Share Analysis, 2023 and 2030 (%)
    • Y-o-Y Growth Analysis, 2019- 2030
    • Segment Trends
  • Hospital Pharmacies
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Million)
  • Retail Pharmacies
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Million)
  • Ecommerce
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Million)

10. Bacterial Sialadenitis Market, By Region, 2018-2030, (US$ Mn)

  • Introduction
    • Market Share Analysis, By Country, 2023 and 2030 (%)
    • Y-o-Y Growth Analysis, For Country 2019-2030
    • Country Trends
  • North America
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Type, 2018-2030, (US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Type of Bacteria, 2018-2030, (US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Gland Type, 2018-2030, (US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2018-2030, (US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2018-2030, (US$ Mn)
    • Market Size and Forecast, By Country, Y-o-Y Growth and By Country, 2018 - 2030, (US$ Mn)
  • U.S.
  • Canada
  • Europe
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Type, 2018-2030, (US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Type of Bacteria, 2018-2030, (US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Gland Type, 2018-2030, (US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2018-2030, (US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2018-2030, (US$ Mn)
    • Market Size and Forecast, By Country, Y-o-Y Growth and By Country, 2018 - 2030, (US$ Mn)
  • U.K.
  • Germany
  • Italy
  • France
  • Spain
  • Russia
  • Rest of Europe
  • Asia Pacific
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Type, 2018-2030, (US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Type of Bacteria, 2018-2030, (US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Gland Type, 2018-2030, (US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2018-2030, (US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2018-2030, (US$ Mn)
    • Market Size and Forecast, By Country, Y-o-Y Growth and By Country, 2018 - 2030, (US$ Mn)
  • China
  • India
  • Japan
  • ASEAN
  • Australia
  • South Korea
  • Rest of Asia Pacific
  • Latin America
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Type, 2018-2030, (US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Type of Bacteria, 2018-2030, (US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Gland Type, 2018-2030, (US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2018-2030, (US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2018-2030, (US$ Mn)
    • Market Size and Forecast, By Country, Y-o-Y Growth and By Country, 2018 - 2030, (US$ Mn)
  • Brazil
  • Mexico
  • Argentina
  • Rest of Latin America
  • Middle East
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Type, 2018-2030, (US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Type of Bacteria, 2018-2030, (US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Gland Type, 2018-2030, (US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2018-2030, (US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2018-2030, (US$ Mn)
    • Market Size and Forecast, By Country, Y-o-Y Growth and By Country, 2018 - 2030, (US$ Mn)
  • GCC
  • Israel
  • Rest of Middle East
  • Africa
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Type, 2018-2030, (US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Type of Bacteria, 2018-2030, (US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Gland Type, 2018-2030, (US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2018-2030, (US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2018-2030, (US$ Mn)
    • Market Size and Forecast, By Country, Y-o-Y Growth and By Country, 2018 - 2030, (US$ Mn)
  • North Africa
  • South Africa
  • Central Africa

11. Competitive Landscape

  • Pfizer Inc.
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Merck & Co., Inc.
  • GlaxoSmithKline plc
  • Novartis AG
  • Sanofi S.A.
  • Johnson & Johnson
  • Abbott Laboratories
  • Eli Lilly and Company
  • AstraZeneca plc.
  • Bayer AG
  • Analyst Views

12. Section

  • Research Methodology
  • About us